Clinical experience with survivin as a biomarker for urothelial bladder cancer

World Journal of Urology

Volumn 28, Issue 3, 2010, Pages 399-404

  Horstmann, Marcus ^a,c   Bontrup, Heike ^b   Hennenlotter, Jörg ^a   Taeger, Dirk ^b   Weber, Anne ^b   Pesch, Beate ^b   Feil, Gerhard ^a   Patschan, Oliver ^a   Johnen, Georg ^b   Stenzl, Arnulf ^a   Brüning, Thomas ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c Kantonsspital Winterthur ^*  (Switzerland)

Author keywords

Bladder cancer; Detection; Survivin; Tumor marker; Urine

Indexed keywords

BIRC5 PROTEIN, HUMAN; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; TUMOR MARKER;

AGE; AGED; ARTICLE; BLADDER TUMOR; CANCER STAGING; CARCINOMA IN SITU; ECHOGRAPHY; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PILOT STUDY; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SURVIVAL; TRANSITIONAL CELL CARCINOMA; TUMOR RECURRENCE; URINE;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; CARCINOMA, TRANSITIONAL CELL; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PILOT PROJECTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RNA, MESSENGER; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEX FACTORS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 77952876524     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-010-0538-2     Document Type: Article

References (19)

1. Barocas DA, Clark PE (2008) Bladder cancer. Curr Opin Oncol 20: 307-314.
2. Noyes K, Singer EA, Messing EM (2008) Healthcare economics of bladder cancer: cost-enhancing and cost-reducing factors. Curr Opin Urol 18: 533-539.
3. Stenzl A, Hennenlotter J, Schilling D (2008) Can we still afford bladder cancer? Curr Opin Urol 18: 488-492.
4. Vrooman OP, Witjes JA (2008) Urinary markers in bladder cancer. Eur Urol 53: 909-916.
5. Lokeshwar VB, Selzer MG (2006) Urinary bladder tumor markers. Urol Oncol 24: 528-537.
6. Herman MP, Svatek RS, Lotan Y, Karakiewizc PI, Shariat SF (2008) Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer. Minerva Urol Nefrol 60: 217-235.
7. Altieri DC (2004) Molecular circuits of apoptosis regulation and cell division control: the survivin paradigm. J Cell Biochem 92: 656-663.
8. Caldas H, Jiang YY, Holloway MP et al (2005) Survivin splice variants regulate the balance between proliferation and cell death. Oncogene 24: 1994-2007.
9. Margulis V, Lotan Y, Shariat SF (2008) Survivin: a promising biomarker for detection and prognosis of bladder cancer. World J Urol 26: 59-65.
10. Smith SD, Wheeler MA, Plescia J, Colberg JW, Weiss RM, Altieri DC (2001) Urine detection of survivin and diagnosis of bladder cancer. JAMA 285: 324-328.
11. Shariat SF, Casella R, Khoddami SM et al (2004) Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer. J Urol 171: 626-630.
12. Wang H, Xi X, Kong X, Huang G, Ge G (2004) The expression and significance of survivin mRNA in urinary bladder carcinomas. J Cancer Res Clin Oncol 130: 487-490.
13. Weikert S, Christoph F, Schrader M, Krause H, Miller K, Muller M (2005) Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis. Int J Cancer 116: 100-104.
14. Kenney DM, Geschwindt RD, Kary MR, Linic JM, Sardesai NY, Li ZQ (2007) Detection of newly diagnosed bladder cancer, bladder cancer recurrence and bladder cancer in patients with hematuria using quantitative rt-PCR of urinary survivin. Tumour Biol 28: 57-62.
15. Sobin LH (ed) (2002) TNM classification of malignant tumours, vol 6. Wiley Liss, New York, pp 199-202.
16. Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143: 29-36.
17. Moussa O, Abol-Enein H, Bissada NK, Keane T, Ghoneim MA, Watson DK (2006) Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer. J Urol 175: 2312-2316.
18. Shariat SF, Ashfaq R, Karakiewicz PI, Saeedi O, Sagalowsky AI, Lotan Y (2007) Survivin expression is associated with bladder cancer presence, stage, progression, and mortality. Cancer 109: 1106-1113.
19. Feil G, Horstmann M, Leng G et al (2008) Urine-based tumor marker tests are a helpful tool in early diagnosis of bladder cancer in high-risk populations-Interim data of the prospective study UroScreen. J Urol 179: 325.